AGP Picks
View all

Press Releases

Stay up to date with press releases covering announcements, company news, product launches, and business updates.

Publish your press release
fallback image
7 hours ago

Zevra Therapeutics Announces Orange Book Listing of U.S. Patent Strengthening Exclusivity for MIPLYFFA

GlobeNewswire, Inc.

fallback image
4 hours ago

Puerto Rico’s Day at the Ballpark Returns for 2026

GlobeNewswire, Inc.

fallback image
Jun. 7, 2026

Attorney General Bonta Announces California DOJ’S Affordability Response Team

Office of the Attorney General California Department of Justice

fallback image
3 hours ago

GENFIT: NASHnext®, Powered by GENFIT's Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp’s OnDemand Offering for Identification of At-Risk MASH

GlobeNewswire, Inc.

fallback image
8 hours ago

Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives

GlobeNewswire, Inc.

fallback image
6 hours ago

Calbee's Single-Serve Asian Style Chips Make Globally Inspired Snacking Easy

EIN Presswire

fallback image
6 hours ago

DAVE & BUSTER’S CELEBRATES GRAND OPENING IN SUGAR LAND

EIN Presswire

fallback image
6 hours ago

Koi Research Labs Expands It's Distribution in USA & Canada

EIN Presswire

fallback image
7 hours ago

Kustom Entertainment, Inc. Announces Partnership with Gilley’s Gambling Hall to Bring Multi-Season Music Festivals to Park City, Kansas

GlobeNewswire, Inc.

fallback image
7 hours ago

Teva’s Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Highlight Long-Term Advances in Tardive Dyskinesia Treatment and Care

GlobeNewswire, Inc.

fallback image
Jun. 6, 2026

U.S., Latin America Bloc Slam Drug-Funded Plot to Topple Bolivia

MENAFN

fallback image
Jun. 7, 2026

Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis

GlobeNewswire, Inc.

fallback image
Jun. 7, 2026

Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity

GlobeNewswire, Inc.

fallback image
9 minutes ago

Artists Announced for for 39th edition of the Lowell Folk Festival July 24-26

EIN Presswire

fallback image
Jun. 7, 2026

India’s RBI Holds Rates at 5.25 Percent, Slashes Growth Outlook

MENAFN

fallback image
Jun. 5, 2026

U.S. Military Reaffirms Commitment to Palauan Communities Amid Ongoing Construction Activities

DVIDS - Georgia

fallback image
Jun. 6, 2026

News Release – DOH Authorizes Reopening of Ohana Sub & Deli, Inc. After Being Closed for Multiple Food Safety Violations

Governor of State of Hawaii

fallback image
Jun. 5, 2026

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

GlobeNewswire, Inc.

fallback image
Jun. 5, 2026

AMASS Brands Group Secures First U.S. Distribution Partner for AMASS Electrolyte Mixers

GlobeNewswire, Inc.

fallback image
Jun. 5, 2026

Village Farms Announces $15 Million Registered Direct Equity Investment from Leading U.S. Institutional Investors

GlobeNewswire, Inc.

Sign up for:

American Food & Beverage Online

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page: